e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Pulmonary hypertension in the clinic
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improved survival in pulmonary hypertension during pregnancy using vasodilator therapy and early elective delivery
D. G. Kiely, C. A. Elliot, V. J. Webster, P. Stewart (Sheffield, United Kingdom)
Source:
Annual Congress 2007 - Pulmonary hypertension in the clinic
Session:
Pulmonary hypertension in the clinic
Session type:
Electronic Poster Discussion
Number:
3284
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. G. Kiely, C. A. Elliot, V. J. Webster, P. Stewart (Sheffield, United Kingdom). Improved survival in pulmonary hypertension during pregnancy using vasodilator therapy and early elective delivery. Eur Respir J 2007; 30: Suppl. 51, 3284
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
Source: Eur Respir J 2012; 40: 1304-1305
Year: 2012
The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Long-term treatment with oral sildenafil in addition to chronic prostacyclin therapy improves pulmonary hemodynamics and six minute walking test in patients with pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002
Favorable pregnancy outcomes in women with predominantly mild pulmonary arterial hypertension
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Year: 2021
Use of iloprost in early pregancy in pulmonary hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005
Good outcomes following elective lower limb orthopaedic surgery in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
One-year observation of iloprost inhalation therapy in patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001
Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Long-term bosentan therapy improves exercise capacity and hemodynamics in sarcoidosis-associated pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012
Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy
Source: Annual Congress 2004 - Pulmonary embolism
Year: 2004
Early detection and management of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 306-312
Year: 2012
Risk assessment and prognosis in patients with pulmonary arterial hypertension receiving intravenous treprostinil
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
Improving survival in pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 218-220
Year: 2005
Pregnancy in pulmonary arterial hypertension: mid-term outcomes of mothers and offspring
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Year: 2021
Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007
Oral anticoagulation therapy in pediatric pulmonary hypertension: A 10-year registry survival analysis
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Improved survival in medically-treated chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept